1 year return (CAGR)
20.36%
Acrivon Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
ACRV
2.01
+0.16 (+8.65%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-43.24%
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
86.14M
Price/Sales
-
Ent value
57.15M
Price/Book
0.99
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 1.89 |
| Daily high | 2.02 |
| Daily low | 1.88 |
| Daily Volume | 334K |
| All-time high | 23.20 |
| 1y analyst estimate | 11.50 |
| Beta | 1.93 |
| EPS (TTM) | -1.77 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ACRV | S&P500 | |
| Current price drop from All-time high | -91.34% | -0.56% |
| Highest price drop | -95.47% | -56.47% |
| Date of highest drop | 30 May 2025 | 9 Mar 2009 |
| Avg drop from high | -72.03% | -10.68% |
| Avg time to new high | 107 days | 12 days |
| Max time to new high | 903 days | 1805 days |
News
